Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-03-01 / Gan To Kagaku Ryoho 2021 Mar;48(3):388-390A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-27 / Ann Surg Oncol 2021 Oct;28(11):6126-6137ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-6139DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2021-02-25 / Neuro Oncol 2021 02;23(2):240-250Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model
/in Hyperthermia, International Publications, Malignant Melanoma /von 2021-02-25 / Front Oncol 2021;11:590764Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues
/in Curcuma, International Publications /von 2021-02-12 / Oncol Lett 2021 Apr;21(4):286Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30,000 cancer deaths per year
/in International Publications, Micronutrients /von 2021-02-04 / Mol Oncol 2021 Feb;The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2021-02-01 / Neurosurg Focus 2021 02;50(2):E8Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-1996
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de